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The proto-oncogene pim-1 was expressed in nine 
human tissues (including epidermis) examined by 
Northern blotting. Expression of pim-1 was also ob-
served in a number of carcinoma-derived keratino-
cyte lines in addition to strains derived from normal 
epidermis . With the exception of a squamous carci-
noma line that exhibits little differentiated character 
in culture (SCC-4), where it was not detected, pim-1 
expression was substantially higher after confluence 
than during log-phase growth in each case. The 
differentiation marker keratinocyte transglutaminase 
showed the same pattern of expression as pim-1 in 
relation to confluence in each of the cell lines and 
strains studied. The influences on pim-1 mRNA lev-
T he proto-oncogene pim-1 was first isolated in mouse T -cell lymphomas as a preferred integration site of the Molony murine leukemi a virus [1] . Its protein product is a 36-kDa cytoplasmic serine/threonine kinase [2] with a short half- life, suggesting that it is a 
' downstream regulator in an as yet unidentified signal-transduction 
pathway. Compared to many other kinases with extensive regula-
tory domains, the small size of pim-1, consisting of li ttle more than 
a kinase domain, raises the possibility it is regulated primarily at the 
message level [3]. It is reportedly expressed primarily in the testis 
( 4], in hematopoietic tissue during mammalian develo pm ent and, in 
adult humans, in circulating granu locytes at low levels [5]. pim-1 
, clearly predisposes transgenic mice to T -cell lymphoma when 
overexpressed and sensitizes them to lymphomagenesis by alkylat-
ing agents or over-expression of other oncogenes such as c-m yc [6]. 
Eleva ted pim-1 expression has been noted in human leukemias [7], 
but no ca usal re latio nship is apparent [5 ,8]. Studying the regulation 
of thjs proto-oncogene may help elu cida te its role in oncogenesis or 
even its normal function. 
Human keratinocytes in culture , which arc shown here to 
ex press the proto-oncogene pim-l, provide a useful model system 
for the study of epidermal ce ll regulation and function. The 
cermiJ1al differentiation program of this ce ll type requires the 
sequential induction of a variety of genes [9 ,1 0]. To e lu cidate the 
molec ular basis for the intrica te regulation that is obscrv t:d and for 
understanding the perturbations that occur in dermatologic dis-
' eases, identifi cation of specific marker proteins is essential. In 
addition to structural proteins (keratins, filaggrin , involucrin) and 
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els of several known effectors of keratinocyte differ-
entiation were studied in the squamous carcinoma 
line SCC-9. pim-1 mRNA was stimulated by hydro-
cortisone and suppressed by the tumor promoter 
tetradecanoyl phorbol acetate. pim-1 mRNA was also 
regulated by calcium ion concentration in the culture 
medium, with expression being threefold higher in 
0.15 mM than in 0.03 mM calcium ion. Keratinocyte 
transglutaminase was regulated similarly by these 
effectors. Thus pim-1 expression was associated with 
keratinocyte differentiation in these cultured cells. 
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surface markers (integrins, cadherins , desmosomal components) . 
enzym es that regulate internal processes, such as keratinocyte 
transglutaminase (TG1, also called TGK), will provide useful tools 
for this purpose. TGl expression is kJ1own to be modulated in 
culture by agen ts pharmacologica lly and tox.icologica11y important 
in the skin, including calcium ion (Ca ++), glucocorticoids, rctin-
oids and phorbol ester rumor promoters [11] . The recent cloning of 
the TGl gene and isolation of the 5 ' -flanking DNA will permit 
investigation of its transet;ptional regulation [1 2]. 
To understand keratinocyte growth and differentiation , con sid-
erable attention is d irected to elucidating signal-transduction pro-
cesses responsible for transcriptional regulation. Tyrosine kinascs , 
through cell-surfa ce growth factor receptors, clearly are criti cal for 
kcratinocyte growth, but have the capacity to regulate transcription 
factor activities [13] and have been implicated in keratinocyte 
differentiation as well , including expression of TG1 [14] and 
probab ly involucrin [15] . C holera toxin improves ket·atinocyte 
growth [16], presumably through stimulation of cA MP-dependent 
kinase activity, but more direct effects of kJ10wn kinases on 
keratinocyte differentiation are largely uncertain. Cells have nu-
merous kinase activities whose interconn ected pathways complicate 
identiftcation of key partic ipants. Nevertheless, activ ities that arc 
regulated coincident with differentiation arc candidates for playing 
criti cal or at least supportive roles. 
MATERJALS AND METHODS 
Cell Culture Squamous carcinoma-derived lines (SCC--l. SCC-9. and 
SCC-1 2F2) [17 .1 8) and papilloma-virus transformed cells (E6/E7) [1 9] 
were inoculated at a density of 2-5 X 105 I I 0-cm dish and grown with 
irradiated 3T3 feeder layer support [20] in Dulbecco's modified Eagle's 
medium and Ham's Fl2 medium (3:1) supplemented with fetal bovine 
serum (5'X•). insulin (5 J.Lg/ ml), transferrin (5 f..lg / ml). T, (20 pM). aden ine 
(0.18 mM) , and hydrocortisone (HC, 0.4 J.Lgl ml) unless otherwise specified. 
The SIK line !21] of spontaneously immortalized keratinocytes (SIK4. 
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SIK23 , and SIK82, passages 4, 23 and 82 , respective ly) and norma l human 
epiderma l ce ll s were inoculated at a density of 4-10 X 105 / 1 0-cm dish with 
feed er la yer support and grown in medium add itiona ll y supplemented with 
epiderma l growth factor (I 0 ng/ml) and . wh<:n passaged, with cholera tox in 
(9 ng/ml) . C ul tures wcr<: treated w ith I f.tM 12-0-tetradecanoylph orbol-
13-ace tate (Tl'A). 1-J C (0. 4 j.Lg/ml). or Ca++ at <:a ch med ium change (twic<: 
\·Vcckly). starting at inocu lario n for C a t+ and a t the fi rst rn c d iun1 change for 
TPA and 1-IC. In experiments to study the efFects ofCa " + . SCC-9 ce ll s w<:rc 
grown in low-Ca + 1 Dtdb<:cco's modified Eagle's medium using feta l 
bov ine se rum (S'Y.•) depleted of Ca " 1 with Chdex-1 00 ion-exchange resin 
I22 J, and ca lcium chloride added to give the indica ted fin al concentration . 
Medin calc illln concen tratio ns \.Vc rc dctc rn1in cd using a Perkin Eln1cr aton1 ic 
abso rption spectrometer. Control cultures were trea ted w ith the appropriate 
so lvent (:S0.1 % fo r dimethylsulfoxide or ethanol. :S1'Yo for water). C ul tures 
were harv<:sted for extraction of RNA 'I week after conflu ence . 
Northern Blotting C ul tu red ke ratinocytes were harvested 7 d afte r 
conflu e n ce cxc:.: pt as in d icated . C u ltures w e re rin sed \>Vith p hosp h ate-
bufFered saline , di sso lved in '1-2 ml of 5-6 M guanidine thiocyanate-0.1 M 
TrisC I (pl-1 7 .5)-1 % 2-mercaptoethanol and <:xtracted imntediatdy o r 
sto red at - 80°C un ti l extraction. RNA was iso lated by CsCI c<:ntrifugation 
123 ]. w ith mod ifications for usc of the Beckman TLl 00 tabletop ul tracen-
trifuge. Tota l ce llular 1"\. N A (15 J.Lg) was electrophoresed thro ugh a 1% 
aga rose ge l containing 0.66 M formaldehyde 124 ] and transfer red to a nylon 
membrane (Schleiclwr and Schuell) . Unifo rm loading of m l"tNA was 
confirmed by comparison w ith the constitutive ly expressed glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) message using a e DNA probe . T he 
membrane was pre-hybridi zed in I M N aC I- 1 00 mM Nal-1 2 P0 .1 (pl-1 
6.5)-1 0 mM cthylenediaminctetraace tic acid (EDTA)-·1% soditlln dodecyl-
sulfatc (SDS)-200 j.Lg/ml yeast tKNA-200 j.Lg/ml sa lmon sperm DNA at 
65 °C for 2-4 h. A mixture of two eDNA probes (pim- 1 or TG I and 
GA PDH). labe led with l.uPidCTP by random priming using Klenow 
po lymerase (Pharmacia o ligo labe ling kit}, was added and hybridized for 
I !3-24 h. T he membrane was washed twice each with 1 M NaCI-50 mM 
Nal-1 2 P0,1- l rnM EDTA- 1% SDS and 0.5 M NaC I- 50 mM Nal-1 2 P0 .1- l 
mM EDTA-0.5% SDS and, if needed , once with 0.5 X SSC-0 .5% SDS 
(1 5- 20 min per wash at 65 °C ) prior to autorad iography. For most experi -
ments, quan titation of rad ioactivity on blots was perform ed by phosphor-
imaging with · GA PDJ-1 signal used to normali ze the pim- 1 or TG I signal. 
Each experiment was performed 2-3 times for pim- 1 express ion. of which 
representative results arc illustrated . !3 lots of mKNA in human tissues 
(C lo ntech, 2 J.Lg po ly A 1 RNA / lane} were probed with "2 1'-l:tbded 
GAPD I-1 and pim- 1 and autorad iogr:tphed ovemight at -80°C with an 
inten sifying screen . pin1- l expression in the ti ssues was conf1nn cd by a 
second blot. Tota l KNA from human epidermis tha t had been released from 
skin by dispase treatment l25] was prepared by Drs. C. Agarwal and 
R. L. Eckert. A sample of 20 p.g was electrophoresed and processed as 
desc ribed above for RNA fi·om cul tures, and the blot probed with 
32 P- labeled GA PDJ-1 and pim-1 probes . 
RESULTS 
Survey of Expression in Human Tissues A multipl e t issue 
Northern blot and an add iti o na l b lot fi·om ep ide rmis o nl y w e re 
probe d f01· p im - 1 (Fig 1). Substanti a l expressio n was o bse rved in a ll 
nine difl:e rentiated tissues ex a min e d (sp leen, thym us, prostate, 
testis, ova ry, sma ll intestine, co lo n, periphe ral b lood le ukocyte, and 
ep iderm is) . Express io n was also o bserved in c ul tured human ke ra-
t inocytes . wh ich were th en studied in detai l to pe rmit exa minatio n 
of p im-l in re lation to the d ifFere n t iated state of th is ce ll type. 
pim-1 Expression in Independently Derived Human Kera-
tinocyte Lines In each of the lines exa min e d , the level of pim-1 
express ion was h igh e r after co nflu e n ce tha n durin g log-phase 
g rowth . Qua nti tated b y phosp ho rim agin g and n orm a lized to 
GAPD H express io n , the express io n leve l wa s 1. 5 to 6.5 times 
g reater afte r conflu ence , d e pe ndin g o n the ce ll lin e. As show n in 
Fig 2, this patte rn wa s seen with the two sq uamous ca rc in o ma-
derived lin es , SCC-9 and SCC-12F2, w ith a papill om a-virus E6/ 
E7-tran sformed lin e , w it h ea rl y and late passages of a spontaneo usly 
immorta li zed ke ratinocyte lin e (SIK4 and SIK82), and w ith norma l 
e p id e rmal ce ll s. An in term ed iate passage of the spon ta neously 
immorta li zed line S IK23 had a re lative ly hig h leve l of pim-1 
express ion be fo re conflu e n ce , w hic h did n ot ch an ge appreciab ly 
afte r confluen ce, proba bl y re fl ectin g the slow g rowth rate and hi gh 
sq uame conten t n oted in this passage. By contrast, the poorly 
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Figure 1. Pim-1 mRNA expression in multiple hu1nan tissues. The 
tissues exa mined by North em blotting were SPL. spleen ; T HY, thymus; 
PRO. prostate; TES , testis; OVA , ovary; !NT, small intestine; CO L, colon; 
Pl3L, peripheral blood leukocytes; and. in a separate ex periment. EP!, 
epidermis. Each sample was probed fo r glyceraldehyde-3-phosphate dehy-
drogenase (GAPD H) as an interna l control. O n the left marg in arc indicated 
tlw rnobilitics of DNA size markers. 
d ifFe re nti ated squamous carc ino m a-derived line SCC-4 r17] d id not 
express appreciabl e pim- 1 mRN A e it her before o r afte r confluen ce. 
It ha s been previously shown that th e keratinocyte diffe re ntiation 
m a rke r TG1 exhibi ts in c rease d express ion afte r conflu e n ce as pan 
of the differentiatio n program [26,27] . In th ese experime n ts, TG1 
showed the sa m e patte rn of exp ress ion in re lation to co nflue nce as 
p im-1 in each of the cell lin es studie d . A represen tative resul t for 
S IK4 is illu strated in Fig 2 . 
Influence of Keratinocyte Differentiation on pim-1 mRNA 
Levels To stud y thi s re la t ionship , th e di fr"c ren tiated state of the 
hig hl y respo n sive SCC-9 cell lin e was modu lated b y severa l known 
e ffectors. T hus, pim-1 mRN A was indu ced two- to threefold by the 
g lucoco rtico id h orm o n e H C at 1 J.LM and suppressed b y a factor of 
two to three by 1 J.LM t reatmen t with th e tumor promoter T PA i.n 
the presen ce ofHC (Fig 3a) . Simil ar ly, TG lmRN A was stimulated 
nin efold by 1-JC, but in the presence of TPA and H C the mRN A 
level was o nl y o ne quarter that in the abse n ce ofTPA (Fig 3b) . In 
an a logous fash io n , w h e n the Ca + -l concentratio n in the m edium 
was 0.15 mM , the level of pim-1 mRNA was three times higher 
th an in m ediu m w ith 0.03 mM Ca +; (Fig 4a). T h e level ofTG1 
mRNA was sixfo ld g reater in m edium w ith the hig he r Ca ++ 
concentrati o n (Fig 4/1). R e su lts w ith an eve n higher Ca + + con-
ce n tratio n of1.4 mM were mu c h li ke those with 0 .15 mM Ca ++. 
g iv in g the same or slj g htl y lower exp ress io n levels for both mRNA 
(not sh own) . T hese find ings are simil ar to the re ported d e pendence 
ofTG 1 express ion o n Ca + I- in cul t ure d m o use epiderma l cell s [28] . 
D ISCUSS ION 
Elevatio n of pim-1 expression has been note d in a number of 
pa tien ts w ith m ye lo id and lympho id leuke mia, but the e levatio n has 
n ot been associa te d with any partic ular ce ll type o r stage of the 
di sease [5 ,8] . In con tra st to the foc us o n cell s of hematopoietic 
o rig in in the li terature [29,30], present findings indi ca te pim-1 is 
expressed at a sig nifi cant level in many human tissues. T hu s, even 
if p im-1 h as a min o r o r neglig ibl e ro le in n eoplasia of human 
he m atopoietic cells, it could be impo rtant in othe r t issues in whjch 
it is expressed. W e ini t iall y h ypothes ized t hat e levated pi.m-1 
expressio n pl ayed a ro le in the immo rtalizatio n ofSIK ce lls, because 
pim-1 is located on the p arm of chromosom e 6, <md the appearance 
of a 6p isochromosome was approx imate ly coinc ide n t with immor-
talizatio n in th ese cell s [2 1] . H owever , in comparison with no rmal 
epid erm a l ce lls, n o corre latio n was evident between pim-1 expres-
sio n and immo rtalizati o n in SIK cell s o r neopla sia in vat;ous 
keratinocyte lin es. M oreover, pim-1 express io n inc reased after 
con flu ence, as the diffe re ntiate d state of th e cultures in creased and 
the fi·action of cells in th e mito t ic poo l genera lly d ecreased. 
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Figure 2. Increased pim-1 mRNA levels after confluence in hutuan keratinocytes. Cultures were harvested 2 d prior to (- ) o r 7 d after confluence ( + ). Samples of tota l R.NA. extracted fro m spontaneously immo rtali zed kc ratinocytes (S I 1<) , squamous ca rcin oma lines (SCC) , an ep ide rmal line 
im mortali zed by papillo ma virus E6 and E7 genes (E6/ E7), and no rmal epidermal ce ll s (hEp). we re examined by N o rthern blotti ng. TG 1 mR..N A levels in 
STK4 arc included in the two lanes at the extreme left for comparison. GA PDH was probed in each sample as an internal control. 
p im-1 appears to partic ipate in developm ent in the he matopoietic 
and repro ductive system s and m ay be in volved in the differentiation 
of a va riety of cell types in whi ch it is cxp1·cssed . For example , it 
regu lates ea rl y 13 lymph opo ies is in mi ce [3 1 ] , and in h um an fetuses, 
it is d evelo pm entall y ex pressed in sites of he m atopo ies is [5]. In 
male mice, moreover, the m essage is expressed in a stage- specific 
man ne r in post-meiotic spcrmatids ( 4] . In keratinocytcs, pim-1 
expressio n is clearl y corre la ted with in crea sed differentiation , 
w hereas a striking la ck of express io n is evide nt in the squam o us 
carcinoma-deri ved lin e SCC- 4, which lacks diftcrcntiatcd features 
in culture . Additionall y, th e depende nce of c1·ythrocytc size on 
pin,-1 exp ress ion levels in transgenic mi ce [32] may have a paral le l 
~ 
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F igure 3. Parallel modulation of p im - 1 and TG1 mRNAs: induc-
tion by HC and suppression by TPA in SCC9 cells. Total RNA from 
COIJAuen t cultures was examined by Northern blotting . GA PDH was 
pro bed in each sample as an in ternal contro l. n) pim-1 mR.NA; b) TGl 
mR.NA . 
in the in creased size of kcratinocytcs (squame formation) during 
terminal diftc rcntiati o n in n o rmal epidermal cells, altho u gh a 
causative ro le he re for the higher levels of pim-1 rem ains specula-
tive. 
Elucidating the fun ction of pim-1 w ill be ass isted by finding the 
signal-transdu ction path ways in which it participates . In cells of the 
m yelo id lineage , pim-1 mRN A is indu ced or stabilized by cytokinc 
g rowth factors [33,34]. In contrast, preliminary experiments w ere 
unsu ccessful in demonstrating epiderma l growth factor stim ulation 
of pim-1 express io n in SIK cultures . By faci li tating early B-cel l 
responses to g rowth facto rs, pim-1 cou ld promote cell surviva l and 
hence m odula te apoptosis. Indeed, resistan ce to dexame thason e-
induced apoptosis has been demonstrated in lymphocytes from 
transgenic mice ovcrcxpress in g pim-1 [35). In a number of in-
stances, however , the ultimate resu lt of oncogene expression 
de pends upon a second signal to inhibit apoptosis, th ereby pe rmit-
ting the cells to progress thro ug h the cell cycle [36,37) . Possibl e 
pim-1 stimu lation of apoprosis as wel l as its influ e nce on g rowth or 
immorta liza tion of cycling kc ratin ocytes arc testable in c ulture by 
transfcctio n experiments . 











Figure 4 . Stimulation of pim-1 mRNA (a) and TG1 mRNA (/J) 
expression in SCC-9 cells grown in 0.15 mM compared to 0.03 ntM 
calciunt ion con centration. Tot:t l l"l.NA \Vas iso lated fi·on1 conAu cnt 
cultures and examined by Northern blotting. GAPDH was probed in each 
s:unplc as an inte rnal contro l. 
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pacterns of expressio n of pim-1 and the d iffe rentiati on marker TG 1, 
a potential m arker for keratin ocyte apoptosis [38), not only with 
respect to con Au en ce but also to the efFects o f Ca + + , H C , and TPA. 
ln volu crin is regul ated sim il arly, but is much more highly sup-
pressed in cultures treated chroni ca lly (e.g., fo r at least several 
medium changes) w ith TPA th an is pim-1. (Unlike chronic treat-
ment [27], exposure to T PA for _short tim es (cf [39]) actually 
stimulates in volucrin ex press io n .) T he pim-1 5' -A anking DNA [40) 
ex hibi ts several traits in commo n with ho usekeep ing genes and th e 
proto-oncogenes N-myc, H-ra s, and th e epiderm al g rowth facto r 
receptor [41-43), in cluding the absen ce of TATA and CAAT 
boxes and a GC-rich p rom oter (7 1%). TG1 [44,45) a lso has 
characteristics of a ho usekeepin g gene [46 - 48], with a CATAA 
box instead of a TATA box, a CAAT box far upstrea m fro m its 
usua l location ( - 396 co mpared to - 80) and a GC-ri ch promoter 
(60%). Comparison of the sequen ces shows both have several 
putative SP1, AP1, AP2, and NF1/CTF sites [40,45), at least some 
of w hich in pim-1 appea r to be fu nctiona l as judged by footp rintin g 
f40) . In severa l systems, TPA and Ca + 1 effects h ave been shown to 
be mediated by APl and/or AP2 c lements [49-51 ], but a recog-
ni za bl e g lu cocorti co id response c le ment has not been identified b y 
in spectio n of the 5'-Aankin g DNA of e ithe r gen e . It m ay be 
antic ipated that further stud y of th e e lements regula ting TG 1 
expression w ill prov ide ins igh t in to regul atio n of pim-1 in kerati-
nocytes and other cell types . 
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